Retrophin, Inc. (RTRX) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Chris Cline – Senior Vice President-Investor Relations and Corporate Communications Eric Dube – Chief Executive Officer Noah Rosenberg – Chief Medical Officer Peter Heerma – Chief Commercial Officer Laura Clague – Chief Financial Officer Bill Rote – Senior Vice President-Research and Development Conference Call Participants Lauri Scoran – Jefferies Chris Clark – SVB Leerink Lina Kaminski – Canaccord Genuity ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________ FORM 10-Q _________________________________ ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-36257 RETROPHIN, INC. (Exact name of registran ...

Retrophin, Inc. (RTRX) Q4 2019 Earnings Conference Call February 24, 2020 4:30 PM ET Company Participants Chris Cline - Vice President, Investor Relations and Corporate Communications Eric Dube - President and Chief Executive Officer Noah Rosenberg - Chief Medical Officer Laura Clague - Chief Financial Officer William Rote - Senior Vice President, Research and Development Peter Heerma - Chief Commercial Officer Conference Call Participants Joseph Schwartz - SVB Leerink Maury Raycroft - Jefferies Jackson Har ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2019 Commission File Number: 001-36257 RETROPHIN, INC. (Exact Name of Registrant as specified in its Charter) Delaware 27-4842691 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 3721 Valley Centre Drive, Suite 200 San Diego, CA 92130 (Address of Princi ...

Retrophin, Inc. (RTRX) Q3 2019 Earnings Conference Call October 30, 2019 4:30 PM ET Company Participants Chris Cline - Vice President, Investor Relations & Corporate Communications Eric Dube - Chief Executive Officer Noah Rosenberg - Chief Medical Officer Laura Clague - Chief Financial Officer William Rote - Senior Vice President, Research & Development Conference Call Participants Joseph Schwartz - SVB Leerink Maury Raycroft - Jefferies Gena Wang - Barclays Bank Christopher Marai - Nomura Instinet Michell ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________ FORM 10-Q _________________________________ ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-36257 RETROPHIN, INC. (Exact name of regis ...

1 Corporate Overview Delivering Life-Changing Therapies to People Living with Rare Diseases October 2019 Forward-Looking Statements This presentation contains forward-looking statements, including statements about our prospects, products, growth projections, competitive position, potential regulatory filings and agency actions, and the anticipated development, timing, data readouts and therapeutic scope of programs in our clinical pipeline. These forwardlooking statements may be accompanied by such words as ...

Retrophin, Inc. (RTRX) Q2 2019 Earnings Conference Call August 6, 2019 4:30 PM ET Company Participants Chris Cline - VP, IR and Corporate Communications Eric Dube - President and CEO Noah Rosenberg - CMO Laura Clague - CFO William Rote - SVP, Research and Development Conference Call Participants Maury Raycroft - Jefferies Group Michelle Gilson - Canaccord Genuity Group Inc. Tim Lugo - William Blair & Co. Joseph Schwartz - SVB Leerink Christopher Marai - Nomura Securities Liisa Bayko - JMP Securities Gena Wa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________ FORM 10-Q _________________________________ ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ___________ Commission File Number: 001-36257 RETROPHIN, INC. (Exact name of registrant ...

Retrophin, Inc. (RTRX) Q1 2019 Earnings Conference Call May 7, 2019 4:30 PM ET Company Participants Chris Cline - Vice President, Investor Relations and Corporate Communications Eric Dube - President and Chief Executive Officer Noah Rosenberg - Chief Medical Officer Laura Clague - Chief Financial Officer William Rote - Senior Vice President, Research and Development Conference Call Participants Greg Harrison - Barclays Bank PLC Tim Lugo - William Blair & Co. Maury Raycroft - Jefferies Group LLC Michelle Gil ...